Series B - Anokion
Investment Firm
Overview
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Announced Date
Sep 11, 2019
Funding Type
Series B
Highlights
Location
Switzerland, Europe
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Anokion raised $40000000 on 2019-09-11 in Series B
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 12, 2011 |  Debt Financing - Anokion | 1 | - | 106.9K |
| Sep 11, 2019 | Series B - Anokion | 4 | - | 40.0M |
| Oct 18, 2022 | Venture Round - Anokion | 1 | - | 35.0M |
| May 09, 2014 | Series A - Anokion | 5 | - | 37.5M |
Recent Activity
There is no recent news or activity for this profile.